Nanoparticles Agents and Secondary Metabolites in Neurodegenerative Diseases

Name: Nanoparticles Agents and Secondary Metabolites in Neurodegenerative Diseases
Price: 354.24 AUD
Availability: OutOfStock
ISBN: 9798337313665

Jawad Laadraoui, Bilal El-Mansoury

$442.95 $354.24

Paperback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We will update you on expected arrival time to us. If this delay is too long, please let us know within 2 business days and we can give you options regarding cancelling or adjusting your order. More details on cancelling your order can be found in our Terms of Trade.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Medical Information Science Reference
14 January 2026

Diseases & disorders; Neurology & clinical neurophysiology; Science: general issues; Nanotechnology

Neurodegenerative diseases, such as Alzheimer's, Parkinson's, and Huntington's, represent some of the most challenging and debilitating conditions affecting the aging population, with limited therapeutic options available. Recent advances in nanotechnology and natural product research open new avenues for intervention. The synergistic potential of engineered nanoparticles and bioactive secondary metabolites, such as flavonoids and terpenoids, crosses biological barriers and modulates oxidative stress and inflammation. This emerging interdisciplinary approach offers promising strategies for medical diagnosis, drug delivery, and disease modification in the fight against neurodegeneration. Nanoparticles Agents and Secondary Metabolites in Neurodegenerative Diseases explores two emerging therapeutic strategies in the treatment of neurodegenerative diseases. It examines the synergistic potential of nanoparticles and secondary metabolites. Covering topics such as neurodegenerative disease, metabolites, and nanoparticles, this book is an excellent resource for academicians, medical and healthcare professionals, engineers, and scientists.

Edited by: Jawad Laadraoui, Bilal El-Mansoury
Imprint: Medical Information Science Reference
Country of Publication: United States
Dimensions: Height: 254mm, Width: 178mm,
ISBN: 9798337313665
Pages: 522
Publication Date: 14 January 2026
Audience: College/higher education , Professional and scholarly , Primary , Undergraduate
Format: Paperback
Publisher's Status: Active

Dr. Jawad Laadraoui is a professor of neurophysiology and neuroscience at the Department of Biology, Faculty of Sciences Ain Chock, Hassan II University of Casablanca, Morocco. His research focuses on neurodegenerative diseases and the effects of natural compounds on brain health, with particular emphasis on the interplay between neuroinflammation, seizure activity, and the therapeutic potential of natural compounds, aiming to develop innovative treatment strategies. Dr. Bilal El-Mansoury is a Professor at the Department of Biology, Faculty of Sciences, Chouaib Doukkali University. He served as a Postdoc Researcher in Neuroscience and Neurology at the Royal College of Surgeons in Ireland, University of Medicine and Health Sciences. His work centers on understanding how glial cells dysfunction contributes to the pathophysiology of hepatic encephalopathy and various neurodegenerative disorders. Dr. El-Mansoury also investigated the role of miRNAs in CDKL5 deficiency disorder, with the aim of identifying novel therapeutic targets for this rare epileptic encephalopathy. In addition to his research, Dr. El-Mansoury is Editor of the Book .